ZNF431
Basic information
Region (hg38): 19:21142024-21196053
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNF431 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 24 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 2 | 0 |
Variants in ZNF431
This is a list of pathogenic ClinVar variants found in the ZNF431 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-21143563-T-C | not specified | Uncertain significance (Nov 14, 2023) | ||
19-21143582-A-G | not specified | Uncertain significance (Dec 06, 2022) | ||
19-21143620-C-G | not specified | Uncertain significance (May 16, 2024) | ||
19-21166407-C-A | not specified | Uncertain significance (Oct 25, 2023) | ||
19-21167571-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
19-21167589-A-G | not specified | Uncertain significance (Apr 13, 2022) | ||
19-21167611-G-A | not specified | Likely benign (Oct 11, 2021) | ||
19-21182658-G-A | not specified | Uncertain significance (Apr 08, 2024) | ||
19-21182707-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
19-21182721-G-C | not specified | Uncertain significance (May 04, 2022) | ||
19-21182743-G-T | not specified | Uncertain significance (May 04, 2022) | ||
19-21182829-T-C | not specified | Uncertain significance (Apr 24, 2024) | ||
19-21182925-A-G | not specified | Uncertain significance (Jul 25, 2023) | ||
19-21182932-G-A | not specified | Uncertain significance (Sep 26, 2023) | ||
19-21182944-G-T | not specified | Likely benign (Nov 23, 2021) | ||
19-21183084-A-C | not specified | Uncertain significance (Nov 10, 2022) | ||
19-21183116-G-C | not specified | Uncertain significance (May 30, 2024) | ||
19-21183231-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
19-21183263-A-T | not specified | Uncertain significance (Dec 22, 2023) | ||
19-21183264-T-A | not specified | Uncertain significance (Apr 28, 2022) | ||
19-21183294-C-T | not specified | Uncertain significance (Feb 26, 2024) | ||
19-21183324-G-A | Malignant tumor of prostate | Uncertain significance (-) | ||
19-21183370-T-G | not specified | Uncertain significance (Feb 22, 2023) | ||
19-21183385-A-C | not specified | Uncertain significance (Aug 02, 2021) | ||
19-21183403-C-A | not specified | Uncertain significance (Aug 23, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZNF431 | protein_coding | protein_coding | ENST00000311048 | 5 | 48208 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0250 | 0.922 | 125715 | 0 | 12 | 125727 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.187 | 278 | 287 | 0.969 | 0.0000128 | 3822 |
Missense in Polyphen | 93 | 109.29 | 0.85097 | 1507 | ||
Synonymous | 1.02 | 85 | 97.8 | 0.869 | 0.00000434 | 983 |
Loss of Function | 1.66 | 4 | 9.54 | 0.419 | 3.98e-7 | 136 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000330 | 0.0000330 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000151 | 0.0000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Sequence-specific DNA binding transcriptional repressor. Represses target gene transcription by recruiting HDAC1 and HDAC2 histone deacetylases. Acts as a specific transcriptional repressor for PTCH1 during embryonic development. Required for osteoblast differentiation and sonic hedgehog/SHH signaling response. Binds to the consensus site 5'-GCGCCC-3' in the promoter of PTCH1 (By similarity). {ECO:0000250}.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription
(Consensus)
Intolerance Scores
- loftool
- 0.779
- rvis_EVS
- 0.33
- rvis_percentile_EVS
- 73.41
Haploinsufficiency Scores
- pHI
- 0.273
- hipred
- N
- hipred_score
- 0.132
- ghis
- 0.468
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.395
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;cell differentiation;negative regulation of DNA-binding transcription factor activity
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;chromatin binding;metal ion binding